{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Biopsy",
      "Magnetic resonance imaging",
      "Prostatic neoplasms",
      "Ultrasonography"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24239473",
  "DateCompleted": {
    "Year": "2015",
    "Month": "05",
    "Day": "12"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "11",
        "Day": "13"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.urolonc.2013.08.006",
      "S1078-1439(13)00316-5"
    ],
    "Journal": {
      "ISSN": "1873-2496",
      "JournalIssue": {
        "Volume": "32",
        "Issue": "6",
        "PubDate": {
          "Year": "2014",
          "Month": "Aug"
        }
      },
      "Title": "Urologic oncology",
      "ISOAbbreviation": "Urol Oncol"
    },
    "ArticleTitle": "Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy.",
    "Pagination": {
      "StartPage": "903",
      "EndPage": "911",
      "MedlinePgn": "903-11"
    },
    "Abstract": {
      "AbstractText": [
        "Recent advances in multiparametric magnetic resonance imaging (MRI) have enabled image-guided detection of prostate cancer. Fusion of MRI with real-time ultrasound (US) allows the information from MRI to be used to direct biopsy needles under US guidance in an office-based procedure. Fusion can be performed either cognitively or electronically, using a fusion device. Fusion devices allow superimposition (coregistration) of stored MRI images on real-time US images; areas of suspicion found on MRI can then serve as targets during US-guided biopsy. Currently available fusion devices use a variety of technologies to perform coregistration: robotic tracking via a mechanical arm with built-in encoders (Artemis/Eigen, BioJet/Geoscan); electromagnetic tracking (UroNav/Philips-Invivo, Hi-RVS/Hitachi); or tracking with a 3D US probe (Urostation/Koelis). Targeted fusion biopsy has been shown to identify more clinically significant cancers and fewer insignificant cancers than conventional biopsy. Fusion biopsy appears to be a major advancement over conventional biopsy because it allows (1) direct targeting of suspicious areas not seen on US and (2) follow-up biopsy of specific cancerous sites in men undergoing active surveillance."
      ],
      "CopyrightInformation": "Copyright \u00a9 2014 Elsevier Inc. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Urology, Stanford University, Stanford, CA."
          }
        ],
        "LastName": "Sonn",
        "ForeName": "Geoffrey A",
        "Initials": "GA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Radiology, University of California, Los Angeles, CA."
          }
        ],
        "LastName": "Margolis",
        "ForeName": "Daniel J",
        "Initials": "DJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Urology, University of California, Los Angeles, CA. Electronic address: lmarks@mednet.ucla.edu."
          }
        ],
        "LastName": "Marks",
        "ForeName": "Leonard S",
        "Initials": "LS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P50 CA092131",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA158627",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 CA195505",
        "Acronym": "CA",
        "Agency": "NCI NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UL1 TR000124",
        "Acronym": "TR",
        "Agency": "NCATS NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Urol Oncol",
    "NlmUniqueID": "9805460",
    "ISSNLinking": "1078-1439"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Image-Guided Biopsy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Magnetic Resonance Imaging"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Prostate"
    },
    {
      "QualifierName": [
        "diagnosis",
        "pathology"
      ],
      "DescriptorName": "Prostatic Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reproducibility of Results"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Ultrasonography, Interventional"
    }
  ]
}